Title:
Ｂ−Ｒａｆ阻害薬、ＥＧＦＲ阻害薬及び場合によってはＰＩ３Ｋ−α阻害薬を含む組合せ医薬
Document Type and Number:
Japanese Patent JP6974669
Kind Code:
B2
Abstract:
A pharmaceutical combination comprising (a) a B-Raf inhibitor, (b) a EGFR inhibitor and, optionally, (c) a PI3K inhibitor; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
More Like This:
| JP7063510 | Recombinant fusion protein targeting CD47 and PD-L1, its preparation and use |
| WO/2009/023819 | TOLL LIKE RECEPTOR MODULATORS |
| JP2008188013 | ANTI-ErbB2 ANTIBODY |
Inventors:
Caponigro, Giordano
Stuart, Dallin
Mutu-du Parsval, Roll
Stuart, Dallin
Mutu-du Parsval, Roll
Application Number:
JP2019174353A
Publication Date:
December 01, 2021
Filing Date:
September 25, 2019
Export Citation:
Assignee:
Array by Offermine Corporation
International Classes:
A61K39/395; A61K31/506; A61K31/517; A61P1/04; A61P35/00; A61P43/00
Foreign References:
| WO2011025927A1 | ||||
| WO2011028540A1 |
Other References:
Nature,2012年 3月,Vol.483,pp.100-104
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki